Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Robert F. Kennedy Jr.
Fierce Pharma
CDER chief Høeg and CBER's Szarama exiting FDA posts
With the ink barely dry on outgoing commissioner Marty Makary’s resignation, more top regulators are heading for the exit at the FDA.
Fraiser Kansteiner
,
Darren Incorvaia
May 15, 2026 1:44pm
Fierce Pharma
FDA's embattled Marty Makary steps down as commissioner
May 12, 2026 2:30pm
Fierce Pharma
FDA advisory committee to discuss action on unapproved peptides
Apr 15, 2026 5:15pm
Fierce Healthcare
States' lawsuit against RFK Jr.'s HHS overhaul moves forward
Apr 9, 2026 7:30am
Fierce Pharma
FDA approves leucovorin without clinical trial—but not for autism
Mar 10, 2026 9:00am
Fierce Pharma
Pfizer CEO Albert Bourla levels criticism of CBER's Vinay Prasad
Mar 3, 2026 4:58pm